These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 24356717)

  • 21. Gene therapy targeting hepatocellular carcinoma by a dual-regulated oncolytic adenovirus harboring the focal adhesion kinase shRNA.
    Gao Y; Zhu Y; Huang X; Ai K; Zheng Q; Yuan Z
    Int J Oncol; 2015 Aug; 47(2):668-78. PubMed ID: 26081241
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Histone deacetylase inhibitor FR901228 enhances the antitumor effect of telomerase-specific replication-selective adenoviral agent OBP-301 in human lung cancer cells.
    Watanabe T; Hioki M; Fujiwara T; Nishizaki M; Kagawa S; Taki M; Kishimoto H; Endo Y; Urata Y; Tanaka N; Fujiwara T
    Exp Cell Res; 2006 Feb; 312(3):256-65. PubMed ID: 16356494
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of the recombinant adenovirus vector AdYB-1: implications for oncolytic vector development.
    Glockzin G; Mantwill K; Jurchott K; Bernshausen A; Ladhoff A; Royer HD; Gansbacher B; Holm PS
    J Virol; 2006 Apr; 80(8):3904-11. PubMed ID: 16571807
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advances in adenovirus-mediated p53 cancer gene therapy.
    Tazawa H; Kagawa S; Fujiwara T
    Expert Opin Biol Ther; 2013 Nov; 13(11):1569-83. PubMed ID: 24107178
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An oncolytic adenovirus selective for retinoblastoma tumor suppressor protein pathway-defective tumors: dependence on E1A, the E2F-1 promoter, and viral replication for selectivity and efficacy.
    Jakubczak JL; Ryan P; Gorziglia M; Clarke L; Hawkins LK; Hay C; Huang Y; Kaloss M; Marinov A; Phipps S; Pinkstaff A; Shirley P; Skripchenko Y; Stewart D; Forry-Schaudies S; Hallenbeck PL
    Cancer Res; 2003 Apr; 63(7):1490-9. PubMed ID: 12670895
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antitumor effects of telomerase-specific replication-selective oncolytic viruses for adenoid cystic carcinoma cell lines.
    Sato D; Kurihara Y; Kondo S; Shirota T; Urata Y; Fujiwara T; Shintani S
    Oncol Rep; 2013 Dec; 30(6):2659-64. PubMed ID: 24065118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. pH-sensitive oncolytic adenovirus hybrid targeting acidic tumor microenvironment and angiogenesis.
    Choi JW; Jung SJ; Kasala D; Hwang JK; Hu J; Bae YH; Yun CO
    J Control Release; 2015 May; 205():134-43. PubMed ID: 25575865
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mre11 inhibition by oncolytic adenovirus associates with autophagy and underlies synergy with ionizing radiation.
    Rajecki M; af Hällström T; Hakkarainen T; Nokisalmi P; Hautaniemi S; Nieminen AI; Tenhunen M; Rantanen V; Desmond RA; Chen DT; Guse K; Stenman UH; Gargini R; Kapanen M; Klefström J; Kanerva A; Pesonen S; Ahtiainen L; Hemminki A
    Int J Cancer; 2009 Nov; 125(10):2441-9. PubMed ID: 19672857
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oncolytic adenoviral mutants induce a novel mode of programmed cell death in ovarian cancer.
    Baird SK; Aerts JL; Eddaoudi A; Lockley M; Lemoine NR; McNeish IA
    Oncogene; 2008 May; 27(22):3081-90. PubMed ID: 18071311
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A survivin-mediated oncolytic adenovirus induces non-apoptotic cell death in lung cancer cells and shows antitumoral potential in vivo.
    Li B; Liu X; Fan J; Qi R; Bo L; Gu J; Qian Q; Qian C; Liu X
    J Gene Med; 2006 Oct; 8(10):1232-42. PubMed ID: 16900558
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased safety with preserved antitumoral efficacy on hepatocellular carcinoma with dual-regulated oncolytic adenovirus.
    Zhang Q; Chen G; Peng L; Wang X; Yang Y; Liu C; Shi W; Su C; Wu H; Liu X; Wu M; Qian Q
    Clin Cancer Res; 2006 Nov; 12(21):6523-31. PubMed ID: 17085667
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oncolytic virotherapy for prostate cancer by E1A, E1B mutant adenovirus.
    Satoh M; Wang H; Ishidoya S; Abe H; Moriya T; Hamada H; Arai Y
    Urology; 2007 Dec; 70(6):1243-8. PubMed ID: 18158069
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of human CD46 and trans-complementation by murine adenovirus 1 fails to allow productive infection by a group B oncolytic adenovirus in murine cancer cells.
    Lei J; Jacobus EJ; Taverner WK; Fisher KD; Hemmi S; West K; Slater L; Lilley F; Brown A; Champion B; Duffy MR; Seymour LW
    J Immunother Cancer; 2018 Jun; 6(1):55. PubMed ID: 29898782
    [TBL] [Abstract][Full Text] [Related]  

  • 34. E1A, E1B double-restricted replicative adenovirus at low dose greatly augments tumor-specific suicide gene therapy for gallbladder cancer.
    Fukuda K; Abei M; Ugai H; Kawashima R; Seo E; Wakayama M; Murata T; Endo S; Hamada H; Hyodo I; Yokoyama KK
    Cancer Gene Ther; 2009 Feb; 16(2):126-36. PubMed ID: 18818710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cancer cell death by design: apoptosis, autophagy and glioma virotherapy.
    Tyler MA; Ulasov IV; Lesniak MS
    Autophagy; 2009 Aug; 5(6):856-7. PubMed ID: 19430207
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oncolytic Replication of E1b-Deleted Adenoviruses.
    Cheng PH; Wechman SL; McMasters KM; Zhou HS
    Viruses; 2015 Nov; 7(11):5767-79. PubMed ID: 26561828
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel immunocompetent murine model for replicating oncolytic adenoviral therapy.
    Zhang L; Hedjran F; Larson C; Perez GL; Reid T
    Cancer Gene Ther; 2015 Jan; 22(1):17-22. PubMed ID: 25525035
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oncolytic replication-competent adenovirus suppresses tumor angiogenesis through preserved E1A region.
    Saito Y; Sunamura M; Motoi F; Abe H; Egawa S; Duda DG; Hoshida T; Fukuyama S; Hamada H; Matsuno S
    Cancer Gene Ther; 2006 Mar; 13(3):242-52. PubMed ID: 16179928
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of E1B gene-attenuated replicating adenoviruses for cancer gene therapy.
    Kim J; Cho JY; Kim JH; Jung KC; Yun CO
    Cancer Gene Ther; 2002 Sep; 9(9):725-36. PubMed ID: 12189522
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficient generation of double heterologous promoter controlled oncolytic adenovirus vectors by a single homologous recombination step in Escherichia coli.
    Hoffmann D; Wildner O
    BMC Biotechnol; 2006 Aug; 6():36. PubMed ID: 16887042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.